hims - Search News

Hims & Hers to offer at-home blood draws and lab testing

Hosted on MSN · 15h

Hims & Hers to offer at-home blood draws, lean into 'peptide innovations' with new acquisitions

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Investopedia on MSN · 2d

Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition

Key Takeaways Shares of Hims & Hers Health touched a fresh record high in Wednesday trading after the company announced its latest acquisition.The company said it acquired Trybe Labs, which will help Hims launch an at-home blood drawing and lab testing service.

GlobalData on MSN · 1d

Hims & Hers to introduce at-home lab testing with Trybe Labs acquisition

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of US-based Trybe Labs. This strategic move is set to enhance the company's ability to offer whole body testing and personalised healthcare solutions directly to customers.

HIMS, Hers Health Stock

Business Insider · 13h

Why Is HIMS Stock Dropping Today?

The U.S. FDA has officially declared that Novo Nordisk’s (NVO) popular diabetes and weight loss therapies, Ozempic and Wegovy, are no longer in

The Motley Fool on MSN · 11h

Why Hims & Hers Health Stock Is Plummeting Today

Shares of Hims & Hers Health ( HIMS -24.30%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as much as 26.1% earlier in the day. The move comes as the S&P 500 lost 1% and the Nasdaq Composite lost 1.3%.

SchaeffersResearch.com · 14h

Hims and Hers Stock Drops Weight as Earnings Loom

Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings

17h

Hims Expands Drug Manufacturing With California Peptide Plant Acquisition

Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...

1h

Hims & Hers Health (HIMS) Projected to Post Quarterly Earnings on Monday

Hims & Hers Health (NYSE:HIMS – Get Free Report) is projected to announce its earnings results after the market closes on ...

10h

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.

1d

Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

7hon MSN

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More

UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...

Money Morning1d

Ozempic Maker Is Ready to Fight Back Against Hims & Hers

Shares of Hims & Hers Health (HIMS) are getting crushed today after the Food & Drug Administration determined there is no ...

17h

Hims & Hers plunges as the FDA says Novo’s weight loss drugs are not in shortage

Hims & Hers Health (HIMS) stock falls as the FDA declares that Novo Nordisk's (NVO) weight loss therapies are no longer in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results